Stephen T. Worland, EVP, Pharmaceuticals at ANADYS PHARMACEUTICALS INC (ANDS), sold 3,000 shares at $14.00 ($42K) on 2006-03-02, disclosed to the SEC on 2006-03-17.
Scheduled sale ($42k) by EVP, Pharmaceuticals under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ANDS | SELL | 2006-03-17 | $64K | — | Filing → |